Novus Cannabis MedPlans is Well-Received at Major ICMG Insurance Conference
Market Changes Gather Interest From Carriers and Wholesalers, Prompting Distribution Agreements To A Larger Target AudienceMIAMI, FL / ACCESSWIRE /...
Staff
AiCuris and Hybridize Therapeutics Enter Worldwide License Agreement of up to €100M for a Direct-Acting RNA-Based Therapy Against BK Virus
AiCuris acquires exclusive rights to develop and commercialize Hybridize's program to prevent severe disease from BK virus (BKV) infections in...
Aptevo Therapeutics Earns $10 Million Non-Dilutive Milestone Payment on Sales of RUXIENCE, Provides Company Update
APVO436 Phase 1b Trial for Acute Myeloid Leukemia Adds New SiteComplete Remission Patient to Advance to TransplantSEATTLE, WA / ACCESSWIRE...
9 Meters Biopharma to Present at the 2022 BIO CEO & Investor Conference
RALEIGH, NC / ACCESSWIRE / February 9, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments...
INVO Bioscience Eyes +20 U.S. Cities To Expand Rollout Of Advanced Infertility Treatment ‘INVO Centers’
SAN FRANCISCO, CA / ACCESSWIRE / February 9, 2022 / Today, the global fertility market is a multi-billion industry, yet...
Sonnet BioTherapeutics Announces Abstract Accepted for Presentation in a Poster Session at the AACR 2022 Annual Meeting
PRINCETON, NJ / ACCESSWIRE / February 9, 2022 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical...
Zomedica Announces Management Team Additions
ANN ARBOR, MI / ACCESSWIRE / February 9, 2022 / Zomedica Corp. (NYSE:ZOM) ("Zomedica" or the "Company"), a veterinary health...
Empower Clinics Launches New Testing Sites in Dallas, Texas
Empower's subsidiary, Kai Medical Laboratory, commences testing at four Dallas, TX area locations generating significant increases in specimen processing and...
Invitation to Conference Call Regarding Promore Pharma’s Year-end Report 2021
STOCKHOLM, SWEDEN / ACCESSWIRE / February 9, 2022 / Promore Pharma (STO:PROMO) (FRA:8T0)STOCKHOLM, 9 February 2022 - Promore Pharma AB...
Philips expands access to hemodynamics at point-of-care for real-time blood flow assessment on Handheld Ultrasound – Lumify
Man undergoing ultrasound in ED Product shot of Philips Lumify handheld ultrasound February 9, 2022 Philips point-of-care ultrasound technology now...
LifeLabs ranked in the top 100 of Canada’s Best Employers of 2022 by Forbes
This is the second consecutive year for LifeLabs to achieve the recognition of being one of Canada’s best employers.Toronto, Ontario,...
AUER CBD Open New Third Location in San Diego; Stocking CBD Products Including Gummies, Tinctures, Oils and Pet Treats
San Diego, Feb. 09, 2022 (GLOBE NEWSWIRE) -- AUER CBD, the health and wellness superstore and online retailer based in...
Wave Life Sciences to Present at the Virtual 11th Annual SVB Leerink Global Healthcare Conference 2022
CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to...
ChemoCentryx to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
SAN CARLOS, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D.,...
Digipath Obtains Coveted Compliance Testing License for California Laboratory
License Provides Steep Hill California Lab with Greatly Expanded Service Offering LAS VEGAS, NV, Feb. 09, 2022 (GLOBE NEWSWIRE) --...
Acarix submits breakthrough designation request with FDA for heart failure diagnosis
Press release Malmö, Sweden, February 9, 2022 Acarix submits breakthrough designation request with FDA for heart failure diagnosis Acarix expands its...
Pharvaris to Participate in 11th Annual SVB Leerink Global Healthcare Conference
ZUG, Switzerland, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company focused on the development and commercialization...
Codex DNA to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
SAN DIEGO, Feb. 09, 2022 (GLOBE NEWSWIRE) -- Codex DNA, Inc. (Nasdaq: DNAY), a pioneer in automated benchtop synthetic biology...
4D Molecular Therapeutics Announces Updated Interim Results from the 4D-310 Phase 1/2 Clinical Trial in Patients with Fabry Disease at the 18th Annual WORLDSymposium
Following discontinuation of ERT, AGA activity was stable at 14-fold mean normal level through week 37 (Patient 1) and stable...
Pasithea Therapeutics Strengthens its Scientific Advisory Board with the Appointment of Preeminent Scientist Dr. Daniel Weinberger
Newest member is a renowned thought leader in the identification of neurobiological mechanisms of mental illnessMIAMI BEACH, Fla., Feb. 09,...